SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Fixed asset impairment charges | $ 0 | $ 0 |
Uninsured cash balances | 19,400,000 | |
Cancer treatment research award | 2,000,000.0 | |
Reduction in research and development | $ 697,000 | |
Minimum | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Property and equipment useful lives | 3 years | |
Share-based compensation expiration period | 12 months | |
Maximum | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Property and equipment useful lives | 10 years | |
Share-based compensation expiration period | 3 years | |
Leasehold improvements | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Property and equipment useful lives | 64 months |
X | ||||||||||
- Definition The cash inflow from the cancer treatment research award. No definition available.
|
X | ||||||||||
- Definition The cash inflow from research and development. No definition available.
|
X | ||||||||||
- Definition Line items represent summary of significant accounting policies. No definition available.
|
X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. No definition available.
|
X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|